AbbVie
Alliance for Genomic Discovery Adds Major Biopharma Partners to Help Fund WGS-Based Biobank
Funding from AbbVie, Amgen, AstraZeneca, Bayer, and Merck will enable DeCode Genetics to sequence an additional 215,000 samples for the alliance.
The biopharma companies are looking to accelerate the completion of UK Biobank Exome Sequencing Consortium data analysis to aid drug discovery.
Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project
The consortium aims to harmonize the use of homologous recombination deficiency as a biomarker to guide certain treatment types in cancer patients.
New Drug Approvals More Likely With Supporting Human Genetic Evidence
AbbVie researchers validated and extended a previous study to find different types of genetic evidence have varying influences on approval prospects.
Adaptive Biotechnologies, AbbVie Partner on MRD Testing in Multiple Myeloma Drug Trials
Amgen's latest deal with a pharma company will see its clonoSeq assay used for minimal residual disease testing in a clinical trial for venetoclax.